Reuters logo
2 个月前
BRIEF-Oncology Venture Sweden to get patent in U.S. for response predictor for anti-cancer drug Irofulven
2017年5月31日 / 下午1点14分 / 2 个月前

BRIEF-Oncology Venture Sweden to get patent in U.S. for response predictor for anti-cancer drug Irofulven

1 分钟阅读

May 31 (Reuters) - ONCOLOGY VENTURE SWEDEN AB:

* SAID ON MONDAY IT HAD BEEN INFORMED BY US PATENT OFFICE THAT IT WILL ALLOW THE CLAIMS IN A PATENT APPLICATION FOR A RESPONSE PREDICTOR FOR ONCOLOGY VENTURES ANTICANCER DRUG IROFULVEN

* A PATENT WILL BE ISSUED BY THE US PATENT OFFICE IN THE NEAR FUTURE

Source text: bit.ly/2rTyMkQ

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below